Clinical Trial Update: Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of new ambroxol hardboiled lozenges for acute pharyngitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pharyngitis

Drugs mentioned

• Ambroxol hardboiled lozenges (new formulation) (ambroxol)

Snippet

Sponsor: Sanofi | Conditions: Pharyngitis | Phase 3 | Status: COMPLETED